Illumina Inc. closed $13.90 short of its 52-week high ($144.02), which the company achieved on January 31st.

The stock's rise snapped a four-day losing streak.

On Thursday, Illumina Inc (ILMN) stock saw a modest uptick, ending the day at $132.27 which represents a slight increase of $6.12 or 4.85% from the prior close of $126.15. The stock opened at $128.04 ...

Illumina Inc (ILMN) stock saw a decline, ending the day at $128.82 which represents a decrease of $-1.28 or -0.98% from the prior close of $130.1. The stock opened at $130.49 and touched a low of $128 ...

We recently compiled a list of the 35 Non-Tech Stocks With Long-Term Investment Potential. In this article, we are going to ...

GRAIL faces financial challenges but holds significant growth potential with its Galleri cancer-screening test. Click here to ...

Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today announced its financial results for the second quarter of fiscal year 2024, which include the consolidated financial results for ...

Genomics is on the brink of revolutionizing healthcare with breakthroughs that could redefine treatment and diagnosis. As ...

(RTTNews) - Illumina, Inc. (ILMN) Tuesday announced that the 432 million euros fine imposed by the European Commission over GRAIL deal is no longer be payable after favorable verdict by the ...

在最近的财经新闻中，代表德克萨斯州第26国会选区的Michael C. Burgess在股票市场进行了一笔重要交易。这笔交易涉及的公司是基因组学行业的领先企业Illumina, Inc. (NASDAQ:ILMN)。 根据众议院书记官发布的定期交易报告，Burgess出售了其持有的部分Illumina, Inc.股票。这笔交易发生在2024年9月3日，正式通知日期为2024年9月5日。 交易的财务 ...

(Bloomberg) -- Illumina Inc.’s blocked $7 billion takeover of cancer-detection provider Grail Inc. should never have been probed by the European Union, according to a top court ruling that ...

(Bloomberg) -- Illumina Inc.’s blocked $7 billion takeover of cancer-detection provider Grail Inc. should never have been probed by the European Union, according to a top court ruling that undermines ...